Effects of fecal microbiota transplantation for recurrent Clostridium difficile infection in children on kidney replacement therapy: a pilot study

No abstract is available for this paper.

• Publication year

  2023

• Venue

  Pediatric nephrology (Berlin, West)

• Publication date

  2023-09-30

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.1007/s00467-023-06168-6PMID 37775582
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Fecal Microbiota Transplant for Clostridioides Difficile Infection Is Safe and Efficacious in an Immunocompromised Cohort

  2022cited by this paper
• Inflammation in Children with CKD Linked to Gut Dysbiosis and Metabolite Imbalance

  2022influential reference
• Effects of short chain fatty acids on metabolic and inflammatory processes in human health.

  2021cited by this paper
• The Role of Microbiota in Infant Health: From Early Life to Adulthood

  2021cited by this paper
• Characterizing the gut microbiota in patients with chronic kidney disease

  2020cited by this paper
• Fecal Calprotectin, CRP and Leucocytes in IBD Patients: Comparison of Biomarkers With Biopsy Results

  2020cited by this paper
• Effects of Fecal Microbiota Transplantation on Composition in Mice with CKD

  2020influential reference
• Fecal Microbiota Transplantation for Treatment of Severe Clostridioides difficile Colitis in a Pediatric Patient With Non-Hodgkin Lymphoma

  2020cited by this paper
• Fecal microbiota transplantation in a toddler after heart transplant was a safe and effective treatment for recurrent Clostridiodes difficile infection: A case report

  2020cited by this paper
• Gut microbiota generation of protein-bound uremic toxins and related metabolites is not altered at different stages of chronic kidney disease.

  2020cited by this paper
• Alterations to the Gut Microbiota and Their Correlation With Inflammatory Factors in Chronic Kidney Disease

  2019cited by this paper
• Uremic Toxin Concentrations are Related to Residual Kidney Function in the Pediatric Hemodialysis Population

  2019cited by this paper
• Fecal Microbiota Transplantation Is Superior to Fidaxomicin for Treatment of Recurrent Clostridium difficile Infection.

  2019cited by this paper
• Fecal microbiota transplantation for refractory diarrhea in immunocompromised diseases: a pediatric case report

  2019cited by this paper
• Quantitative microbiome profiling disentangles inflammation- and bile duct obstruction-associated microbiota alterations across PSC/IBD diagnoses

  2019cited by this paper
• Gastrointestinal Microbiota in Patients with Chronic Kidney Disease: A Systematic Review.

  2019cited by this paper
• Safety and Pharmacokinetic Study of Fidaxomicin in Children With Clostridium difficile–Associated Diarrhea: A Phase 2a Multicenter Clinical Trial

  2018influential reference
• A Systematic Review of the Efficacy and Safety of Fecal Microbiota Transplant for Clostridium difficile Infection in Immunocompromised Patients

  2018cited by this paper
• Development of the Pediatric Gut Microbiome: Impact on Health and Disease

  2018cited by this paper
• Concentrations of representative uraemic toxins in a healthy versus non-dialysis chronic kidney disease paediatric population

  2018cited by this paper
• Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA).

  2018cited by this paper
• Fecal microbiota transplantation for the treatment of recurrent and severe Clostridium difficile infection in solid organ transplant recipients: A multicenter experience

  2018cited by this paper
• Para-cresol production by Clostridium difficile affects microbial diversity and membrane integrity of Gram-negative bacteria

  2018cited by this paper
• Furan fatty acids - Beneficial or harmful to health?

  2017cited by this paper
• Spontaneous variability of pre-dialysis concentrations of uremic toxins over time in stable hemodialysis patients

  2017cited by this paper
• European consensus conference on faecal microbiota transplantation in clinical practice

  2017cited by this paper
• Quantitative microbiome profiling links gut community variation to microbial load

  2017cited by this paper
• Gut microbiota in chronic kidney disease.

  2017cited by this paper
• Changes in microbial ecology after fecal microbiota transplantation for recurrent C. difficile infection affected by underlying inflammatory bowel disease

  2017cited by this paper
• The gut–kidney axis

  2017cited by this paper
• Evaluation of the impact of gut microbiota on uremic solute accumulation by a CE-TOFMS-based metabolomics approach.

  2017cited by this paper
• The Leaky Gut and Altered Microbiome in Chronic Kidney Disease.

  2017cited by this paper
• Clostridium difficile Infection in Special High-Risk Populations

  2016cited by this paper
• A liquid chromatography - tandem mass spectrometry method to measure a selected panel of uremic retention solutes derived from endogenous and colonic microbial metabolism.

  2016cited by this paper
• The Human Intestinal Microbiome in Health and Disease.

  2016cited by this paper
• Frequency and risks associated with Clostridium difficile‐associated diarrhea after pediatric solid organ transplantation: a single‐center retrospective review

  2016cited by this paper
• DADA2: High resolution sample inference from Illumina amplicon data

  2016cited by this paper
• A reduction in the butyrate producing species Roseburia spp. and Faecalibacterium prausnitzii is associated with chronic kidney disease progression

  2016cited by this paper
• Population-level analysis of gut microbiome variation

  2016influential reference
• The human gut microbiome in health: establishment and resilience of microbiota over a lifetime

  2016cited by this paper
• Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection

  2015cited by this paper
• Clostridium difficile infection.

  2015cited by this paper
• Fecal Microbiota in Pediatric Inflammatory Bowel Disease and Its Relation to Inflammation

  2015cited by this paper
• Microbiome changes associated with sustained eradication of Clostridium difficile after single faecal microbiota transplantation in children with and without inflammatory bowel disease

  2015cited by this paper
• Clostridium difficile infection

  2014cited by this paper
• Fecal Microbiota Transplantation for Refractory Clostridium difficile Colitis in Solid Organ Transplant Recipients

  2014cited by this paper
• Fecal Microbiota Transplant for Treatment of Clostridium difficile Infection in Immunocompromised Patients

  2014cited by this paper
• High-throughput DNA sequence analysis reveals stable engraftment of gut microbiota following transplantation of previously frozen fecal bacteria

  2013cited by this paper
• Clostridium difficile Infections in Solid Organ Transplantation

  2013cited by this paper
• Monitoring microbiological changes in drinking water systems using a fast and reproducible flow cytometric method.

  2013cited by this paper
• Chronic kidney disease alters intestinal microbial flora.

  2013cited by this paper
• Publisher's Note

  2003cited by this paper

• The gut-kidney axis in pediatric acute kidney injury: a review of pathophysiological mechanisms and therapeutic frontiers.

  2026cites this paper
• Gut microbiota-targeted therapies in pediatric chronic kidney disease: gaps and opportunities

  2025cites this paper
• A Critical Review on the Potential of Inactivated Bacteria in Counteracting Human Pathogens

  2025cites this paper
• Effectiveness and Safety of Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection in Immunocompromised Patients.

  2025cites this paper
• Fecal microbiota spores, live-brpk (VOWST™/VOS) for prevention of recurrent Clostridioides difficile infection.

  2024cites this paper